Related Experiment Video
Updated: May 25, 2026
Analysis of Coronary Vessels in Cleared Embryonic Hearts
Published on: December 7, 2016
Cyclooxygenase immunohistochemical staining in the human ductus arteriosus after 24 weeks of gestational age
Abstract:
Cyclooxygenase inhibitors (CI) which contained risks to fetal health were one of the most effective tocolytics. In order to indirectly investigate the effects of CI in human ductus arteriosus, immunohistochemical staining for cyclooxygenase-1 (COX1) and cyclooxygenase-2 (COX2) was evaluated in post-mortem fetuses with gestational ages between 24 and 34 weeks. Neither COX1 nor COX2 staining was related to gestational age. COX1 and COX2 staining in the vessel walls were not related to each other. COX1 staining in the endothelium, inner media and outer media were positively correlated with each other (COX1 endothelium vs IM staining Spearman's rho statistic [rs] = 0.721, p = 0.001; COX1 endothelium vs OM staining [rs] = 0.634, p = 0.004; COX1 IM vs OM staining [rs] = 0.931, p = 0.001). COX2 staining of endothelium was not correlated with either IM or OM staining. In conclusion, COX2 staining in the post-mortem specimens of human ductus arteriosus between 24 and 34 weeks is weak and limited to the endothelium.
Insights
Cyclooxygenase inhibitors (CI) are effective tocolytics but pose fetal risks. This study examined cyclooxygenase-1 (COX1) and cyclooxygenase-2 (COX2) in fetal ductus arteriosus, finding COX2 expression weak and limited to the endothelium.
Area of Science:
- Perinatal Medicine
- Developmental Biology
- Pharmacology
Background:
- Cyclooxygenase inhibitors (CI) are potent tocolytics used to prevent preterm birth.
- Concerns exist regarding CI's potential risks to fetal health, particularly affecting the ductus arteriosus.
- Understanding CI's impact requires investigating the expression of cyclooxygenase enzymes within the fetal ductus arteriosus.
Purpose of the Study:
- To investigate the expression patterns of cyclooxygenase-1 (COX1) and cyclooxygenase-2 (COX2) in the human fetal ductus arteriosus.
- To determine if COX1 and COX2 expression correlates with gestational age or with each other in fetuses between 24 and 34 weeks.
- To indirectly assess the potential impact of CI on the ductus arteriosus by examining the localization and correlation of COX enzymes.
Main Methods:
- Post-mortem human fetal specimens (gestational age 24–34 weeks) were analyzed.
- Immunohistochemical staining was employed to detect COX1 and COX2 expression.
- Staining intensity and localization in the endothelium, inner media, and outer media were evaluated and correlated with gestational age and each other.
Main Results:
- Neither COX1 nor COX2 staining showed a significant relationship with gestational age.
- COX1 staining was positively correlated across different layers of the ductus arteriosus vessel wall (endothelium, inner media, outer media).
- COX2 staining was weak, primarily localized to the endothelium, and did not correlate with COX1 staining or other vessel wall layers.
Conclusions:
- COX2 expression in the human fetal ductus arteriosus (24–34 weeks) is minimal and confined to the endothelium.
- The observed COX1 expression patterns suggest coordinated activity within the ductus arteriosus wall.
- These findings provide a baseline for understanding cyclooxygenase activity in the fetal ductus arteriosus and its potential modulation by CI.
